Results 241 to 250 of about 84,715 (301)

Ketorolac 0.45% Ophthalmic Solution

Drugs & Aging, 2011
Ketorolac 0.45% ophthalmic solution is a topical NSAID indicated in the US for the treatment of ocular pain and inflammation following cataract surgery. In animal studies, the ocular relative bioavailability of single-dose topical ketorolac 0.45% ophthalmic solution was 2- to 3-fold higher than that of ketorolac 0.4% ophthalmic solution.
openaire   +2 more sources

pH Stability of ophthalmic solutions

Optometry - Journal of the American Optometric Association, 2004
In this study, we evaluated the pH value of 17 ophthalmic solutions, and we investigated whether the pH of these solutions changed over time after the bottle was opened.Fifteen bottles of each type of solution were chosen at random from different production lots. A 0.05-ml increment was taken from each bottle and was measured daily using a micropH 2002
Monica, Garcia-Valldecabres, Antonio, López-Alemany, Miguel F, Refojo   +2 more
openaire   +2 more sources

Stability of Pilocarpine Ophthalmic Solutions

Drug Development and Industrial Pharmacy, 1999
The stability of pilocarpine and pilocarpine-timolol eyedrop preparations available on the Argentine market was studied. A high-performance liquid chromatographic method that allows the estimation of pilocarpine in the presence of degradation products was used for the study according to the preestablished design. It was found that pilocarpine solutions
C, Pilatti, M C, Torre, C, Chiale, M, Spinetto   +3 more
openaire   +2 more sources

Ophthalmic Solutions

Journal of the American Pharmaceutical Association (1961), 1961
Kurt Kleinmann, C. Lee Huyck
openaire   +2 more sources

OPHTHALMIC SOLUTIONS

Optometry and Vision Science, 1974
R M, Hill, J E, Terry
openaire   +2 more sources

INTAL OPHTHALMIC SOLUTION

Medical Journal of Australia, 1976
openaire   +3 more sources

Self-Sterilizing Ophthalmic Solutions

American Journal of Ophthalmology, 1949
S D, McPHERSON, R M, WOOD
openaire   +2 more sources

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

ophthalmic solutions

Journal of the American Pharmaceutical Association (Practical Pharmacy ed.), 1958
Sidney Riegelman, Daniel G. Vaughan
openaire   +1 more source

Ophthalmic Solutions

Journal of the American Pharmaceutical Association (Practical Pharmacy ed.), 1946
Louis Arrigoni, G.A. Tozer
openaire   +1 more source